BioMarin to Participate in Goldman Sachs 12th Annual Healthcare CEOs Unscripted: A View from the Top on January 9, 2020 in New YorkHomeMailNewsFinanceSportsEntertainmentSearchMobileMore...YAHOO_FINANCESearchSign inMailSign in to view your mailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets closedS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)BioMarin to Participate in Goldman Sachs 12th Annual Healthcare CEOs Unscripted: A View from the Top on January 9, 2020 in New YorkPR NewswireJanuary 8, 2020ReblogShareTweetShareSAN RAFAEL, Calif., Jan. 8, 2020 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer, will present at Goldman Sachs 12th Annual Healthcare CEOs Unscripted: A View from the Top on January 9, 2020 at 8:45am ET in New York.  To access the live webcast, please visit the investor section of the BioMarin website, www.biomarin.com. A replay will also be archived on the site for at least one week following each event.BioMarin Pharmaceutical logo (PRNewsfoto/BioMarin Pharmaceutical Inc.)MoreAbout BioMarin BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of seven commercialized products and multiple clinical and pre-clinical product candidates.  For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release. Contacts:
Investors
Media
Traci McCarty
Debra Charlesworth
BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
(415) 455-7558
(415) 455-7451
CisionMoreView original content to download multimedia:http://www.prnewswire.com/news-releases/biomarin-to-participate-in-goldman-sachs-12th-annual-healthcare-ceos-unscripted-a-view-from-the-top-on-january-9-2020-in-new-york-300983241.htmlSOURCE BioMarin Pharmaceutical Inc.ReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextCitigroup, Goldman, JPMorgan Slash Earnings Estimates for StocksBloombergHere are 5 reasons the stock market is having its worst decline since 2008, and only one of them is the coronavirusMarketWatchUS, European stocks plunge, extending rout amid virus fearsAFPSycamore Gets $1 Billion In Deal That Amazed StreetBloombergCoronavirus Hits US Stocks, Bitcoin Climbs, Haven Status UnclearCoindeskBiocontainment expert on coronavirus: There's no need for average people to panic yetYahoo FinanceA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance VideoStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance VideoIs Link Administration Holdings Limited (ASX:LNK) Trading At A 50% Discount?Simply Wall St.'Stuck in no man’s land': A working mom details dealing with her sick child's student loan billYahoo FinanceMost face masks won’t protect you from the coronavirusYahoo FinanceDon’t buy the stock dip yet, says Goldman as it warns coronavirus will wipe out earnings growth this yearMarketWatchCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance Video